Vaccine development against Schmallenberg virus: from classical inactivated to modified-live to scaffold particle vaccines
Abstract Background Subsequent to its first detection in 2011, the insect-transmitted bunyavirus Schmallenberg virus (SBV; genus Orthobunyavirus) caused a large-scale epizootic of fetal malformation in the European ruminant population. By now, SBV established an enzootic status in Central Europe wit...
Saved in:
Main Authors: | Kerstin Wernike (Author), Andrea Aebischer (Author), Jean-Christophe Audonnet (Author), Martin Beer (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Virus-Like Particle Vaccines
Published: (2020) -
Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
by: Xiaolan Yong, et al.
Published: (2023) -
Ebola virus - prospects for a novel virus-like-particle-expressing modified vaccinia Ankara-based vaccine
by: Harriet L. Robinson, et al.
Published: (2018) -
30-Year Development of Inactivated Virus Vaccine in China
by: Jinrong Shi, et al.
Published: (2023) -
Suspended cell lines for inactivated virus vaccine production
by: Jiayou Zhang, et al.
Published: (2023)